[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100656104":3},{"organization":4,"outcomesModule":7,"designInfo":31,"detailedDescription":30,"studyPopulation":30,"armGroups":43,"interventions":54,"overallOfficials":62,"centralContacts":67,"locations":72,"responsibleParty":105,"collaborators":108,"id":111,"slug":112,"hasResults":113,"nctId":114,"briefTitle":115,"officialTitle":115,"acronym":30,"eligibilityCriteria":116,"healthyVolunteers":117,"sex":118,"minAge":119,"maxAge":30,"enrollmentInfo":120,"targetDuration":30,"studyType":123,"phases":124,"briefSummary":126,"conditions":127,"keywords":130,"overallStatus":75,"whyStopped":30,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":146},{"fullName":5,"class":6},"University of Copenhagen","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":30},[9],{"measure":10,"description":11,"timeFrame":12},"Glucagon-like peptide 1","Plasma concentration","From baseline samples (-15, 0 min) until the end of the meal test at t = 180min",[14,16,18,20,22,24,26,28],{"measure":15,"description":11,"timeFrame":12},"Glucose",{"measure":17,"description":11,"timeFrame":12},"Gastrin",{"measure":19,"description":11,"timeFrame":12},"Cholecystokinin",{"measure":21,"description":11,"timeFrame":12},"Glucose-dependent insulinotropic polypeptide (GIP)",{"measure":23,"description":11,"timeFrame":12},"C-peptide",{"measure":25,"description":11,"timeFrame":12},"Glucagon",{"measure":27,"description":11,"timeFrame":12},"Pancreatic polypeptide",{"measure":29,"description":11,"timeFrame":12},"3-OMG",null,{"allocation":32,"interventionModel":33,"interventionModelDescription":34,"primaryPurpose":35,"observationalModel":30,"timePerspective":30,"maskingInfo":36},"RANDOMIZED","CROSSOVER","Randomised double blind placebo-controlled trial","BASIC_SCIENCE",{"masking":37,"maskingDescription":38,"whoMasked":39},"TRIPLE","identical capsules containing Paracetamol and placebo is prepared by the pharmacy",[40,41,42],"PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR",[44,49],{"label":45,"type":46,"description":30,"interventionNames":47},"Paracetamol (1000mg)","ACTIVE_COMPARATOR",[48],"Other: Paracetamol",{"label":50,"type":51,"description":30,"interventionNames":52},"Placebo","PLACEBO_COMPARATOR",[53],"Other: Placebo",[55,59],{"type":6,"name":56,"description":57,"armGroupLabels":58,"otherNames":30},"Paracetamol","Paracetamol is used as a tool to block prostaglandin synthesis",[45],{"type":6,"name":50,"description":60,"armGroupLabels":61,"otherNames":30},"A placebo will be administered to be able to determine the effect of paracetamol on prostaglandin synthesis",[50],[63],{"name":64,"affiliation":65,"role":66},"Simon Veedfald, MD, PhD","Department of BIomedical Scienes, University Copenhagen","PRINCIPAL_INVESTIGATOR",[68],{"name":64,"role":69,"phone":70,"phoneExt":30,"email":71},"CONTACT","+45 41102595","veedfald@sund.ku.dk",[73,93],{"facility":74,"status":75,"city":76,"state":77,"zip":78,"country":79,"countryCode":80,"cosmosGeoPoint":81,"geoPoint":86,"contacts":87},"Department of Biomedical Sciences, The Panum Institute, University of Copenhagen,","RECRUITING","Copenhagen","Capital","2200","Denmark","DK",{"type":82,"coordinates":83},"Point",[84,85],12.56553,55.67594,{"lat":85,"lon":84},[88,90],{"name":89,"role":69,"phone":70,"phoneExt":30,"email":71},"Simon Veedfald, MD, PhD.",{"name":91,"role":69,"phone":30,"phoneExt":30,"email":92},"Jonatan Friis, MD","jonatan.sverri.kure.friis@sund.ku.dk",{"facility":94,"status":75,"city":95,"state":30,"zip":96,"country":79,"countryCode":80,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Hvidovre Hospital, Copenhagen University Hospital","Hvidovre","2650",{"type":82,"coordinates":98},[99,100],12.47708,55.64297,{"lat":100,"lon":99},[103],{"name":91,"role":69,"phone":30,"phoneExt":30,"email":104},"Jonatan.sverri.kure.friis@regionh.dk",{"type":66,"investigatorFullName":106,"investigatorTitle":107,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Simon Veedfald","Assistant professor",[109],{"name":110,"class":6},"Hvidovre University Hospital","100656104","does-paracetamol-influence-the-release-of-gut-hormones-glucose-absorption-and-glycemia-100656104",false,"NCT07821515","Does Paracetamol Influence the Release of Gut Hormones, Glucose Absorption and Glycemia?","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Nondiabetic fasting plasma glucose (\\\u003C 7.0 mmol\u002FL) at time of inclusion\n* BMI of 20-25\n* Written informed consent\n\nExclusion Criteria:\n\n* Haemoglobin \\\u003C 7.9 mmol\u002FL\n* Pregnancy or breastfeeding\n* Significant gastrointestinal symptoms (e.g. dyspepsia, postprandial pain)\n* Use of medication that cannot be paused for 12 hours or any drug that affects gastric emptying, small intestinal motility, glucose absorption.\n* Use of paracetamol, NSAID, aspirin or similar within the previous week.\n* Evidence of drug abuse, consumption of tobacco in any form or daily consumption of more than 20g alcohol\n* History of gastrointestinal disease, including significant upper or lower gastrointestinal symptoms, pancreatitis, or previous gastrointestinal surgery including cholecystectomy (but not uncomplicated appendicectomy)\n* Participation in other research studies within the previous 3 months\n* Inability to give informed consent\n* Intolerance to any of the components of paracetamol and the meals used for the study",true,"ALL","18 Years",{"count":121,"type":122},12,"ESTIMATED","INTERVENTIONAL",[125],"NA","The study aim is to determine whether acute inhibition of endogenous prostaglandin synthesis by paracetamol affects the release of gut hormones, glucose absorption and glycemia in healthy young individuals",[128,129],"Healthy Young Adults","Physiology",[131,132,133,56,134,135,136],"prostaglandins","glucose","gut hormones","GLP-1","GIP","meal test","2026-09-09",{"date":139,"type":140},"2026-09-15","ACTUAL",{"date":142,"type":140},"2026-06-01",{"date":144,"type":122},"2026-12-31",{"name":5,"class":6},2]